Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates

Journal of Viral Hepatitis

Volumn 6, Issue 2, 1999, Pages 135-139

  Vranckx, R ^a   Alisjahbana, A ^b   Meheus, A ^c  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b PADJADJARAN UNIVERSITY   (Indonesia)

^c UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

HBV markers; HBV vaccine; Hepatitis B; Immune tolerance; Newborns; Non responsiveness

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN;

ACTIVE IMMUNIZATION; ARTICLE; CLINICAL TRIAL; DISEASE MARKER; DRUG EFFICACY; HEPATITIS B; HUMAN; IMMUNE RESPONSE; INDONESIA; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; NEWBORN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SEROCONVERSION; TREATMENT FAILURE; TREATMENT OUTCOME; VERTICAL TRANSMISSION; VIRUS CARRIER;

BIOLOGICAL MARKERS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VACCINATION;

EID: 0033012297     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1999.00145.x     Document Type: Article

References (23)

1. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 229: 771-774.
2. Ghendon Y. Perinatal transmission of hepatitis B virus in high-incidence countries. J Virol Methods 1987; 17: 69-79.
3. Barin F, Goudeau A, Denis F et al. Immune response in neonates to hepatitisB vaccine. Lancet 1982; i: 251-253.
4. Lee GCY, Hwang LY, Beasley RP, Chen SH, Lee TY. Immunogenicity of hepatitis B vaccine in healthy Chinese neonates. J Infect Dis 1983; 148: 526-529.
5. Prozesky OW, Stevens CE, Szmuness W et al. Immune response to hepatitis B virus vaccine in newborns. J Infect 1983; 7 (Suppl 1): 53-55.
6. Tang SX, Yu GL. Intrauterine infection with hepatitis B virus (letter). Lancet 1990; i: 302.
7. Ip HMH, Lelie PN, Wong VCW, Kuhns MC, Reesink HW. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989; i: 406-410.
8. Vranckx R, Alisjahbana A, Ngantung W et al. Anti-HBs kinetics after HBV vaccination in neonates. Clin Diag Virol 1994; 2: 343-348.
9. Stevens CE, Neurath RA, Beasley RP, Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol 1979; 3: 237-241.
10. Beasley R, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977; 105: 94-98.
11. Mushawar IK, McGrath LC, Drnec J, Overby LR. Radioimmunoassay for detection of hepatitis B e antigen and its antibody. Results of clinical evaluation. Am J Clin Pathol 1981; 76: 692-697.
12. Lazizi Y, Badur S, Perk Y, Ilter O, Pillot J. Selective unresponsiveness to HBsAg vaccine in newborns related with an in utero passage of hepatitis B virus DNA. Vaccine 1997; 15: 1095-1100.
13. Gerety RJ. Maternal transmission of hepatitis B (letter). N Engl J Med 1976; 295: 170.
14. Chircu LV, Mattiacci M, Schiano G, Franco E, Patella A, Reverberi L. HBs and anti-HBs survey in mother/infant pairs (letter). Lancet 1975; ii: 706.
15. Milich DR, Jones JE, Hughes JL, Price J, Ranay AK, McLachlan A. Is a function of the secreted hepatitis Be antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci USA 1990; 87: 6599-6603.
16. Goudeau A, Yvonnet B, Lesage G et al. Lack of anti-HBc IgM in neonates with HBsAg carrier mothers argues against transplacental transmission of hepatitis B virus infection. Lancet 1983; ii: 1103-1104.
17. Alexander GJM, Eddleston ALW. Does maternal antibody to core antigen prevent recognition of transplacental transmission of hepatitis B virus infection? Lancet 1986; i: 296-297.
18. Belloni C, Tinelli C, Orsolini P et al. Revaccination against hepatitis B virus of non-responding and low-responding infants immunised at birth. A parallel evaluation of rubella and tetanus vaccine. Vaccine 1998; 16: 399-402.
19. Usonis V, Kühnl P, Brede HD, Doerr HW. Humoral immune response after hepatitis B vaccination: kinetics of anti-HBs antibodies and demonstration of HLA antigens. Zbl Bakt Hyg A 1986; 262: 377-384.
20. Alper CA, Kruskall MS, Marcus-Bagley D et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989; 321: 708-712.
21. Vranckx R. The humoral and cellular immunity in asymptomatic HBsAg carriers. Bull Instit Pasteur 1978; 78: 283-293.
22. Thomas HC, Thursz MR. Immunogenetics of hepatitis B infection. J Viral Hep 1997; 4 (suppl 2): 98-100.
23. Thursz MR. Host genetic factors influencing the outcome of hepatitis. J Viral Hep 1997; 4: 215-220.